交易 DISC MEDICINE ORD - IRON
Disc Medicine, Inc. (NASDAQ: IRON) is a clinical-stage biopharmaceutical company developing therapies for hematologic diseases caused by dysregulated iron homeostasis. Its pipeline targets both rare and chronic blood disorders with novel mechanisms of action. Disc Medicine’s shares move with clinical trial results, regulatory updates, and investor sentiment toward innovative rare-disease treatments.最新股票文章

SpaceX上市首日收涨19%——IPO后如何交易SpaceX SPCX差价合约
SpaceX(SPCX)于2026年6月12日在纳斯达克首次上市,开盘报150美元,收盘报160.95美元,较135美元的IPO发行价上涨19.2%。
08:41, 16 六月 2026


